Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment
Journal of Alzheimer’s Disease · 2026-05 · 111 (2) · 675-688
DOI: 10.1177/13872877261435429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 30.03.2026. Verfasst von Xitian Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Haiyang People's Hospital, Haiyang, China. Hauptthemen laut MEDLINE: tau Proteins, Apolipoprotein E4, Cognitive Dysfunction, Amyloid beta-Peptides. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, National Natural Science Foundation of China, Yantai Natural Science Foundation Project.
Abstract (Originalsprache)
Background
Mild cognitive impairment (MCI) confers an increased risk of Alzheimer's disease (AD). The apolipoprotein E ( APOE ) ε4 allele is a major genetic risk factor for late-onset AD and is strongly associated with amyloid-β (Aβ) pathology. However, whether Aβ burden is associated with APOE ε4-related longitudinal changes in tau pathology, neurodegeneration, and cognitive decline in MCI remains incompletely understood.
Objective
To examine whether Aβ burden is associated with APOE ε4-related longitudinal changes in tau pathology, neurodegeneration, and cognition in MCI using ε4 carrier-based and genotype-stratified approaches.
Methods
Data from 396 individuals with MCI in the Alzheimer's Disease Neuroimaging Initiative were analyzed. Longitudinal changes in cerebrospinal fluid (CSF) tau biomarkers, neurodegeneration, and cognition were quantified using individual-specific slopes and examined in multiple linear regression models in relation to APOE ε4 carrier status and Aβ burden. Mediation analyses were used to quantify the associations between baseline Aβ burden and APOE ε4-related longitudinal changes across ε4 carrier-based and genotype-stratified analyses.
Results
APOE ε4 carriers showed greater longitudinal increases in CSF tau and more pronounced declines in glucose metabolism, regional brain volumes, and cognition. Baseline Aβ burden showed associations with APOE ε4-related longitudinal changes in CSF tau, cerebral glucose metabolism, brain atrophy, and memory and global cognition. A similar pattern was also observed in genotype-stratified analyses.
Conclusions
These longitudinal findings suggest that Aβ burden is closely associated with APOE ε4-related tau accumulation, neurodegeneration, and cognitive decline in individuals with MCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Haiyang People's Hospital, Haiyang, China.
- Department of Neurology, Jiaozhou Branch of Shanghai East Hospital, Tongji University, Jiaozhou, China.
- Department of General Internal Medicine, Jiaozhou Branch of Shanghai East Hospital, Tongji University, Jiaozhou, China.
- Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Neurology, Yantaishan Hospital, Yantai, China.
- Department of Neurology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
ORCID-Profile: Maowen Ba
Förderung
- Key Technology Research and Development Program of Shandong Province
- National Natural Science Foundation of China
- Yantai Natural Science Foundation Project
Zitieren
APA
Wang, X., Zhang, C., Liu, X., Tai, Y., Ma, G., Kong, M., Ba, M., & for Alzheimer's Disease Neuroimaging Initiative (2026). Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment. Journal of Alzheimer’s Disease, 111(2), 675-688. https://doi.org/10.1177/13872877261435429
Vancouver
Wang X, Zhang C, Liu X, Tai Y, Ma G, Kong M, et al. Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment. Journal of Alzheimer’s Disease. 2026;111(2):675-688. doi:10.1177/13872877261435429
BibTeX
@article{Wang2026,
author = {Wang, Xitian and Zhang, Chunhua and Liu, Xiaocong and Tai, Yaojun and Ma, Guozhao and Kong, Min and Ba, Maowen and for Alzheimer's Disease Neuroimaging Initiative, for Alzheimer's Disease Neuroimaging Initiative},
title = {Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
volume = {111},
number = {2},
pages = {675--688},
doi = {10.1177/13872877261435429}
}
EUVIMED